Aim: Multiple sclerosis (MS), which is inflammatory in its pathogenesis, damages the myelin sheath in the central nervous system (CNS) and causes axonal loss. Epicardial fat tissue (EFT), located between the myocardium and the visceral layer of the pericardium, surrounds the heart and several inflammatory cytokines is secreted from this tissue. In this study, we aimed to investigate EFT thickness in MS patients and compared with that of volunteer non-MS subjects. Methods: A total of 154 subjects comprising 61 MS patients and 93 volunteers matched for gender and age were included in our study. Epicardial fat tissue thickness was measured by echocardiography. All values were compared between groups.Results: Echocardiographic parameters were similar in both groups. However, the mean EFT thickness was significantly higher in the MS group than in the control group (p
 Belbasis L, Bellou V, Evangelou E, et al. Environmental risk factors and multiple sclerosis: An umbrella review of systematic reviews and metaanalyses. Lancet Neurol. 2015;14(3):263–73.
 Sawcer S, Franklin RJ, Ban M. Multiple sclerosis genetics. Lancet Neurol. 2014;13(7):700–9.
 Brück, W, Stadelmann C. The spectrum of multiple sclerosis: new lessons from pathology. Curr Opin Neurol. 2005;18(3):221–24.
 Hohlfeld R, Kerschensteiner M, Stadelmann C, et al. The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis. J Neuroimmunol. 2000;107(2):161-66.
 Sacks HS, Fain JN. Human epicardial adipose tissue: a review. Am Heart J. 2007;153(6): 907-17.
 Şengul C, Özveren O. Epicardial adipose tissue: a review of physiology, pathophysiology, and clinical applications. Anadolu Kardiyol Derg. 2013;13(3):261-65.
 Mazurek T, Zhang L, Zalewski A, et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation. 2003;108(20):2460-66.
 Kim SH, Chung JH, Kwon BJ, et al. The Associations of Epicardial Adipose Tissue With Coronary Artery Disease and Coronary Atherosclerosis. Int Heart J. 2014;55(3):197-203.
 Imitola J, Chitnis T, Khoury SJ. Cytokines in multiple sclerosis: from bench to bedside. Pharmacol Ther. 2005;106(2):163- 77.
 Stys PK. Multiple sclerosis: autoimmune disease or autoimmune reaction? Can J Neurol Sci. 2010;37(S2):S16-S23.
 Asik M, Sahin S, Ozkul F, et al. Evaluation of epicardial fat tissue thickness in patients with Hashimoto thyroiditis. Clin Endocrinol. 2013;79(4):571-76.
 Fatma E, Bunyamin K, Savas S, et al. Epicardial fat thickness in patients with rheumatoid arthritis. Afr Health Sci. 2015;15(2):489-95.
 Iacobellis G, Barbaro G. The double role of epicardial adipose tissue as pro-and antiinflammatory organ. Horm Metab Res. 2008;40(07):442-45.
 Iacobellis G, Assael F, Ribaudo MC, et al. Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes Res. 2003;11(2):304-10.
 Jadidi E, Mohammadi M, Moradi T. High risk of cardiovascular diseases after diagnosis of multiple sclerosis. Mult Scler. 2013;19(10):1336–40.
 Christiansen CF, Christensen S, Farkas DK, et al. Risk of arterial cardiovascular diseases in patients with multiple sclerosis: a population‐based cohort study. Neuroepidemiology. 2010;35(4):267 –74.
 Allen NB, Lichtman JH, Cohen HW, et al. Vascular disease among hospitalized multiple sclerosis patients. Neuroepidemiology. 2008;30(4):2 34–38.
 Lindegard B. Diseases associated with multiple sclerosis and epilepsy. A population cohort study of 159,200 middleaged, urban, native Swedes observed over 10 years (1970–79). Acta Neurol Scand. 1985;71(4):267–77.
 Roshanisefat H, Bahmanyar S, Hillert J, et al. Multiple sclerosis clinical course and cardiovascular disease risk–S wedish cohort study. Eur J Neurol. 2014;21(11):1353-e88.
 Moccia M, Lanzillo R, Palladino R, et al. The Framingham cardiovascular risk score in multiple sclerosis. Eur J Neurol. 2015;22(8):1176-83.
 Yuksel B, Koc P, Ozaydin Goksu E, et al. Is multiple sclerosis a risk factor for atherosclerosis? J Neuroradiol. 2019; 7:S0150-9861(19)30462-66.
 Wens I, Dalgas U, Stenager E, et al. Risk factors related to cardiovascular diseases and the metabolic syndrome in multiple sclerosis – a systematic review. Mult Scler. 2013;19(12):1556-64.
 Pierdomenico SD, Pierdomenico AM, Neri M, et al. Epicardial adipose tissue and metabolic syndrome in hypertensive patients with normal body weight and waist circumference. Am J Hypertens. 2011;24(11):1245-49.
 Brück W, Stadelmann C. Inflammation and degeneration in multiple sclerosis. Neurol Sci. 2003;24(5):265-67.
 Frischer JM., Bramow S, Dal-Bianco A, et al. The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain. 2009;132(5):1175-89.
 Ramirez-Ramirez V, Macias-Islas MA, Ortiz GG, et al. Efficacy of fish oil on serum of TNF α, IL-1 β, and IL-6 oxidative stress markers in multiple sclerosis treated with interferon beta-1b. Oxid Med Cell Longev. 2013;2013:709493.
 Sharief MK, Hentges R. Association between tumor necrosis factor-α and disease progression in patients with multiple sclerosis. N Engl J Med. 1991;325(7): 467- 72.